Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boxer

Showing results (211-220 of 328) with videos related to

Pageof 33
Sort By:
Alzheimer Disease and Associated Disorders|March 23, 2013
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer diseaseSuzee E Lee, Maria C Tartaglia, Görsev Yener, et al.
NPJ Dementia|May 28, 2026
Early onset rapidly progressive frontotemporal dementia due to a novel MAPT P301A variant with functional validation of pathogenicityKiet Hua, Maryam R Pearson, Brandon I Apresa, et al.
Brain : a Journal of Neurology|May 9, 2015
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationSylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMolly Olzinski, Yann Cobigo, Rowan Saloner, et al.
Annals of Neurology|October 6, 2017
<sup>18</sup> F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R Schonhaut, Corey T McMillan, Salvatore Spina, et al.
JAMA Neurology|April 4, 2022
Subcortical Neuronal Correlates of Sleep in Neurodegenerative DiseasesJun Y Oh, Christine M Walsh, Kamalini Ranasinghe, et al.
Neurology Open Access|April 16, 2026
Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal DementiaEmily W Paolillo, Amy Wise, Jeffrey A Kaye, et al.
JAMA Neurology|February 10, 2025
Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based BiomarkersLawren VandeVrede, Hanna Cho, Mark Sanderson-Cimino, et al.
JAMA Neurology|November 12, 2019
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical TrialRichard M Tsai, Zachary Miller, Mary Koestler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 10, 2012
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug developmentAdam L Boxer, Michael Gold, Edward Huey, et al.
Pageof 33

Showing results (211-220 of 328) with videos related to

Sort By:
Pageof 33
Alzheimer Disease and Associated Disorders|March 23, 2013
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer diseaseSuzee E Lee, Maria C Tartaglia, Görsev Yener, et al.
NPJ Dementia|May 28, 2026
Early onset rapidly progressive frontotemporal dementia due to a novel MAPT P301A variant with functional validation of pathogenicityKiet Hua, Maryam R Pearson, Brandon I Apresa, et al.
Brain : a Journal of Neurology|May 9, 2015
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationSylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMolly Olzinski, Yann Cobigo, Rowan Saloner, et al.
Annals of Neurology|October 6, 2017
<sup>18</sup> F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R Schonhaut, Corey T McMillan, Salvatore Spina, et al.
JAMA Neurology|April 4, 2022
Subcortical Neuronal Correlates of Sleep in Neurodegenerative DiseasesJun Y Oh, Christine M Walsh, Kamalini Ranasinghe, et al.
Neurology Open Access|April 16, 2026
Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal DementiaEmily W Paolillo, Amy Wise, Jeffrey A Kaye, et al.
JAMA Neurology|February 10, 2025
Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based BiomarkersLawren VandeVrede, Hanna Cho, Mark Sanderson-Cimino, et al.
JAMA Neurology|November 12, 2019
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical TrialRichard M Tsai, Zachary Miller, Mary Koestler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 10, 2012
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug developmentAdam L Boxer, Michael Gold, Edward Huey, et al.
Pageof 33